정현호

정현호, listed as chief executive, appears in our data through filings on 메디톡스 shares, published by DART (FSS). Over a trading history stretching from 26 February 2021 to 28 August 2026, the count stands at 58 filings.

Every open-market trade on record is a purchase: 18 purchases, and no sale. The totals exclude 18 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at 7 purchases and no sales.

Across 10 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The record was last updated on 28 August 2026 with a transaction in 메디톡스. The last insider purchase was made public on 3 August 2026, 76 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 5 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.